STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma

G3: Genes, Genomes, Genetics

Volumn 3, Issue 12, 2013, Pages 2173-2185

  Hardee, Jennifer ^a,b   Ouyang, Zhengqing ^a,d,e,f   Zhang, Yuping ^a,b   Kundaje, Anshul ^a,c   Lacroute, Philippe ^a   Snyder, Michael ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c Stanford University   (United States)

^d JACKSON LABORATORY   (United States)

^e UNIVERSITY OF CONNECTICUT   (United States)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cancer signaling; Genomics; Next generation sequencing; Oncogenic pathways; Signal transduction

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D2; FIBROBLAST GROWTH FACTOR 2; FLICE INHIBITORY PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1BETA; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; JANUS KINASE 1; JANUS KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 10; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN KINASE C ALPHA; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BINDING SITE; CANCER GROWTH; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DNA BINDING; WESTERN BLOTTING;

CANCER SIGNALING; GENOMICS; NEXT-GENERATION SEQUENCING; ONCOGENIC PATHWAYS; SIGNAL TRANSDUCTION;

BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84890841710     PISSN: None     EISSN: 21601836     Source Type: Journal    
DOI: 10.1534/g3.113.007674     Document Type: Article

References (86)

1. Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos et al., 2000 Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.
2. Alvarez, J. V., and D. A. Frank, 2004 Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol. Ther. 3: 1045-1050.
3. American Cancer Society, 2012 Cancer Facts & Figures-2012. American Cancer Society, Atlanta.
4. Anders, S., and W. Huber, 2010 Differential expression analysis for sequence count data. Genome Biol. 11: R106.
5. Anderson, J. J., S. Fordham, L. Overman, H. Dignum, K. Wood et al., 2009 Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics. Int. J. Oncol. 35: 961-971.
6. Angelin-Duclos, C., G. Cattoretti, K. I. Lin, and K. Calame, 2000 Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165: 5462-5471.
7. Arigami, T., S. Natsugoe, Y. Uenosono, S. Yanagita, H. Arima et al., 2009 CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int. J. Oncol. 35: 19-24.
8. Avery,D. T., E. K.Deenick, C. S.Ma, S. Suryani, N. Simpson et al., 2010 B cellintrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207: 155-171.
9. Baker, S. J., S. G. Rane, and E. P. Reddy, 2007 Hematopoietic cytokine receptor signaling. Oncogene 26: 6724-6737.
10. Benekli,M.,M. R. Baer, H. Baumann, andM.Wetzler, 2003 Signal transducer and activator of transcription proteins in leukemias. Blood 101: 2940-2954.
11. Benjamini, Y., and Y. Hochberg, 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57: 289-300.
12. Besson, A., and V. W. Yong, 2000 Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol. Cell. Biol. 20: 4580-4590.
13. Blankenberg, D., G. Von Kuster, N. Coraor, G. Ananda, R. Lazarus et al., 2010 Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. Jan: Chapter 19: Unit 19.10.1-21.
14. Blenk, S., J. Engelmann, M. Weniger, J. Schultz, M. Dittrich et al., 2007 Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform. 3: 399-420.
15. Brady, G., G. J. MacArthur, and P. J. Farrell, 2007 Epstein-Barr virus and Burkitt lymphoma. J. Clin. Pathol. 60: 1397-1402.
16. Burkle, A.,M.Niedermeier, A. Schmitt-Graff,W.G.Wierda, M. J. Keating et al., 2007 Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 110: 3316-3325.
17. Cao, Y., R. Cao, and E. M. Hedlund, 2008 R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J. Mol. Med. (Berl.) 86: 785-789.
18. Castillo, J., L. Pantanowitz, and B. J. Dezube, 2008 HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am. J. Hematol. 83: 804-809.
19. Da, M. X., Z. Wu, and H. W. Tian, 2008 Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch. Med. Res. 39: 365-372.
20. Ding, B. B., J. J. Yu, R. Y. Yu, L. M. Mendez, R. Shaknovich et al., 2008 Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 111: 1515-1523.
21. Drexler, H. G., 2010 Guide to Leukemia-Lymphoma Cell Lines. German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
22. Echlin, D. R., H. J. Tae, N. Mitin, and E. J. Taparowsky, 2000 B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19: 1752-1763.
23. Falini, B., M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti et al., 2000 A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95: 2084-2092.
24. Fornek, J. L., L. T. Tygrett, T. J. Waldschmidt, V. Poli, R. C. Rickert et al., 2006 Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 107: 1085-1091.
25. Fu, K., D. D. Weisenburger, W. W. Choi, K. D. Perry, L. M. Smith et al., 2008 Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. J. Clin. Oncol. 26: 4587-4594.
26. Giardine, B., C. Riemer, R. C. Hardison, R. Burhans, L. Elnitski et al., 2005 Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15: 1451-1455.
27. Gilby, D. C., H. Y. Sung, P. R. Winship, A. C. Goodeve, J. T. Reilly et al., 2010 Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia. Immunol. Lett. 130: 115-124.
28. Goecks, J., A. Nekrutenko, and J. Taylor, 2010 Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11: R86.
29. Han, Y., T. Meng, N. R. Murray, A. P. Fields, and A. R. Brasier, 1999 Interleukin-12induced nuclear factor-kappaB-IkappaBalpha autoregulatory feedback loop in hepatocytes. A role for protein kinase calpha in post-transcriptional regulation of ikappabalpha resynthesis. J. Biol. Chem. 274: 939-947.
30. Han, Y., H. M. Amin, B. Franko, C. Frantz, X. Shi et al., 2006 Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 108: 2796-2803.
31. Hans, C. P., D. D. Weisenburger, T. C. Greiner, R. D. Gascoyne, J. Delabie et al., 2004 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282.
32. Hodge, D. R., E. M. Hurt, and W. L. Farrar, 2005 The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41: 2502-2512.
33. Hu, C., J. Xiong, L. Zhang, B. Huang, Q. Zhang et al., 2004 PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. Cell. Mol. Immunol. 1: 280-294.
34. Huttemann, M., I. Lee, L. I. Grossman, J. W. Doan, and T. H. Sanderson, 2012 Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease. Adv. Exp. Med. Biol. 748: 237-264.
35. Ishida, K., M. Iwahashi, M. Nakamori, M. Nakamura, S. Yokoyama et al., 2009 High CCR7 mRNA expression of cancer cells is associated with lymph node involvement in patients with esophageal squamous cell carcinoma. Int. J. Oncol. 34: 915-922.
36. Kasowski, M., F. Grubert, C. Heffelfinger, M. Hariharan, A. Asabere et al., 2010 Variation in transcription factor binding among humans. Science 328: 232-235.
37. Kharchenko, P. V., M. Y. Tolstorukov, and P. J. Park, 2008 Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat. Biotechnol. 26: 1351-1359.
38. Kodama, J., T. Hasengaowa, N. Kusumoto, T. Seki, Matsuo et al., 2007 Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann. Oncol. 18: 70-76.
39. Koster, A., and J. M. Raemaekers, 2005 Angiogenesis in malignant lymphoma. Curr. Opin. Oncol. 17: 611-616.
40. Lan, Q., T. Zheng, N. Rothman, Y. Zhang, S. S. Wang et al., 2006 Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107: 4101-4108.
41. Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg, 2009 Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10: R25.
42. Lansigan, F., D. M. Stearns, and F. Foss, 2010 Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma. Cancer Manag Res 2: 53-59.
43. Latini, F. R., J. P. Hemerly, B. C. Freitas, G. Oler, G. J. Riggins et al., 2011 ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence. BMC Cancer 11: 11.
44. Lenz, G., G. Wright, S. S. Dave, W. Xiao, J. Powell et al., 2008 Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359: 2313-2323.
45. Li, D., K. Achilles-Poon, S. F. Yu, R. Dere, M. Go et al., 2013 DCDT2980S, an anti-CD22-monomethyl auristatin e antibody-drug conjugate, is a potential treatment for non-Hodgkins lymphoma. Mol Cancer Ther. 12: 1255-1265.
46. Li, Q., J. B. Brown, H. Huang, and P. J. Bickel, 2011 Measuring reproducibility of high-throughput experiments. Ann. Appl. Stat. 5: 1752-1779.
47. Liang, H., X. Ding, C. Zhou, Y. Zhang, M. Xu et al., 2012 Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells. Neurol. Sci. 33: 1057-1062.
48. Liao, J., S. E. Humphrey, S. Poston, and E. J. Taparowsky, 2011a Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. Mol. Cancer Res. 9: 350-363.
49. Liao, W., F. Y. Goh, R. J. Betts, D. M. Kemeny, J. Tam et al., 2011b A novel anti-apoptotic role for apolipoprotein L2 in IFN-gamma-induced cytotoxicity in human bronchial epithelial cells. J. Cell. Physiol. 226: 397-406.
50. Lin, Q., R. Lai, L. R. Chirieac, C. Li, V. A. Thomazy et al., 2005 Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167: 969-980.
51. Logan, M. R., K. L. Jordan-Williams, S. Poston, J. Liao, and E. J. Taparowsky, 2012 Overexpression of Batf induces an apoptotic defect and an associated lymphoproliferative disorder in mice. Cell Death Dis. 3: e310.
52. Lu, P. P., Z. Y. Meng, M. X. Zhou, M. W. Wang, and G. F. Dou, 2006 Immunotherapy of non-Hodgkin's lymphomas (NHL) by anti-CD22 antibody. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14: 1258-1261 (review in Chinese).
53. Lu, Z., G. Jiang, P. Blume-Jensen, and T. Hunter, 2001 Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21: 4016-4031.
54. Maltepe, E., B. Keith, A. M. Arsham, J. R. Brorson, and M. C. Simon, 2000 The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia. Biochem. Biophys. Res. Commun. 273: 231-238.
55. McLean, C. Y., D. Bristor, M. Hiller, S. L. Clarke, B. T. Schaar et al., 2010 GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28: 495-501.
56. Minegishi, Y., 2009 Hyper-IgE syndrome. Curr. Opin. Immunol. 21: 487-492.
57. Morin, R., M. Bainbridge, A. Fejes, M. Hirst, M. Krzywinski et al., 2008 Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 45: 81-94.
58. Motoyama, M., S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta, 2005 Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein. J. Biol. Chem. 280: 7444-7451.
59. Nakata, B., S. Fukunaga, E. Noda, R. Amano, N. Yamada et al., 2008 Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 74: 69-75.
60. Olsson, A., M. Norberg, A. Okvist, K. Derkow, A. Choudhury et al., 2007 Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br. J. Cancer 97: 769-777.
61. Ouyang, Z., Q. Zhou, and W. H. Wong, 2009 ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA 106: 21521-21526.
62. Pallesen, G., S. J. Hamilton-Dutoit, M. Rowe, and L. S. Young, 1991 Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322.
63. Pan,M. R.,M. F. Hou, H. C. Chang, and W. C. Hung, 2008 Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. J. Biol. Chem. 283: 11155-11163.
64. Park, S., J. Lee, Y. H. Ko, A. Han, H. J. Jun et al., 2007 The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110: 972-978.
65. R Development Core Team, 2008 R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.
66. Rosenwald, A., G. Wright, W. C. Chan, J. M. Connors, E. Campo et al., 2002 The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346: 1937-1947.
67. Rothman, N., C. F. Skibola, S. S. Wang, G. Morgan, Q. Lan et al., 2006 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 7: 27-38.
68. Schimanski, C. C., R. Bahre, I. Gockel, T. Junginger, N. Simiantonaki et al., 2006 Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer. Oncol. Rep. 16: 109-113.
69. Shao, R. H., X. Tian, G. Gorgun, A. G. Urbano, and F. M. Foss, 2002 Arginine butyrate increases the cytotoxicity of DAB(389)IL-2 in leukemia and lymphoma cells by upregulation of IL-2Rbeta gene. Leuk. Res. 26: 1077-1083.
70. Shuai, K., G. R. Stark, I. M. Kerr, and J. E. Darnell, Jr., 1993 A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261: 1744-1746.
71. Siu, L. L., J. K. Chan, and Y. L. Kwong, 2002 Natural killer cell malignancies: clinicopathologic and molecular features. Histol. Histopathol. 17: 539-554.
72. Suzuki, K., H. Nakajima, Y. Saito, T. Saito, W. J. Leonard et al., 2000 Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. Int. Immunol. 12: 123-132.
73. Sweetenham, J. W., 2005 Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. Hematology (Am Soc Hematol Educ Program) 252-259.
74. The ENCODE Project Consortium, R. M. Myers, J. Stamatoyannopoulos, M. Snyder, I. Dunham et al., 2011 A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9: e1001046.
75. Tirado, C. A., W. Chen, R. Garcia, K. A. Kohlman, and N. Rao, 2012 Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large b-cell lymphoma: a review of the literature. J Hematol Oncol 5: 54.
76. Turkson, J., 2004 STAT proteins as novel targets for cancer drug discovery. Expert Opin. Ther. Targets 8: 409-422.
77. Warnes, G. R., B. Bolker, L. Bonebakker, R. Gentleman, W. Huber et al., 2011 gplots: Various R programming tools for plotting data. Available at: http://cran.r-project.org/web/packages/gplots/index.html. Accessed October 28, 2013.
78. Wen, Z., Z. Zhong, and J. E. Darnell, Jr., 1995 Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
79. Wright, G., B. Tan, A. Rosenwald, E. H. Hurt, A. Wiestner et al., 2003 A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 100: 9991-9996.
80. Wu, Z. L., Y. Q. Song, Y. F. Shi, and J. Zhu, 2011 High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma. J Hematol Oncol 4: 31.
81. Yan, J., M. Enge, T. Whitington, K. Dave, J. Liu et al., 2013 Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites. Cell 154: 801-813.
82. Yang, S. Y., A. Miah, A. Pabari, and M. Winslet, 2011 Growth factors and their receptors in cancer metastases. Front. Biosci. 16: 531-538.
83. Yu, G. H., K. T. Montone, D. Frias-Hidvegi, R. S. Cajulis, B. A. Brody et al., 1996 Cytomorphology of primary CNS lymphoma: review of 23 cases and evidence for the role of EBV. Diagn. Cytopathol. 14: 114-120.
84. Zhang, X., J. Blenis, H. C. Li, C. Schindler, and S. Chen-Kiang, 1995 Requirement of serine phosphorylation for formation of STATpromoter complexes. Science 267: 1990-1994.
85. Zhong, Z., Z. Wen, and J. E. Darnell, Jr., 1994 Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98.
86. Zhu, B. M., K. Kang, J. H. Yu, W. Chen, H. E. Smith et al., 2012 Genomewide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes. Nucleic Acids Res. 40: 4461-4472.